Pacific Biosciences of California, Inc. (PACB)
NASDAQ: PACB · Real-Time Price · USD
1.390
-0.100 (-6.71%)
At close: Jul 17, 2025, 4:00 PM
1.400
+0.010 (0.72%)
Pre-market: Jul 18, 2025, 5:43 AM EDT

PACB Revenue

Pacific Biosciences of California had revenue of $37.15M in the quarter ending March 31, 2025, a decrease of -4.27%. This brings the company's revenue in the last twelve months to $152.36M, down -23.99% year-over-year. In the year 2024, Pacific Biosciences of California had annual revenue of $154.01M, down -23.19%.

Revenue (ttm)
$152.36M
Revenue Growth
-23.99%
P/S Ratio
2.57
Revenue / Employee
$264,969
Employees
575
Market Cap
417.12M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024154.01M-46.51M-23.19%
Dec 31, 2023200.52M72.22M56.29%
Dec 31, 2022128.30M-2.21M-1.69%
Dec 31, 2021130.51M51.62M65.43%
Dec 31, 202078.89M-12.00M-13.20%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.